April 04, 2018
Rose
San Francisco-based Virta Health has announced the closing of a $45 million Series B funding round for its digitally-delivered, drug- and surgery-free Type 2 diabetes treatment. Previous investors Venrock, Obvious Ventures, Creandum, Caffeinated Capital, and SciFi VC participated in the round, with new investors including Founders Fund and Playground Global joining as well.
from MobiHealthNews https://ift.tt/2q5Iz4g
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment